Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» VEGF
VEGF
The world's twelfth VEGF drug will be sold by Takeda
EP Vantage
Mon, 01/23/23 - 10:43 am
Takeda
Hutchmed
VEGF
fruquintinib
XyloCor bags $23M to expand heart disease gene therapy R&D
Fierce Biotech
Mon, 03/22/21 - 10:46 am
XyloCor Therapeutics
gene therapy
VEGF
heart disease
clinical trials
R&D